Latest Inostics GmbH Stories
HAMBURG, Germany, May 11, 2011 /PRNewswire/ -- In response to the growing interest in the sensitive blood-test for the detection of tumor-specific DNA-molecules, Inostics GmbH (Hamburg, Germany) has founded a US subsidiary. Inostics' non-invasive test based on the BEAMing-Technology is one of the most sensitive methods available today for the detection of tumor specific mutations and is already used in studies by pharmaceutical and biotechnology companies.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).